Home / Life Sciences / Key developments and materials / Weekly highlights

Legal News

Life Sciences weekly highlights—13 October 2022

Copyright © 2025 LexisNexis

Published on: 13 October 2022

Published by a LexisNexis Life Sciences expert

imgtext

Article summary

This week's edition of Life Sciences weekly highlights includes news that the European Association Medical devices of Notified Bodies (Team-NB) has published a framework for the verification process for Class D in vitro diagnostic medical devices by Notified Bodies in the absence of designated EU Reference Laboratories alongside a best practice guide on the submission of Technical Documentation under Annexes II and III of Regulation (EU) 2017/745 (the Medical Devices Regulation), the European Commission issued a statement of objections to Teva in relation to its multiple sclerosis drug Copaxone, the National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency were awarded £1.8m to explore digital mental health tools, £10.65m in additional funding was given to a new vaccine innovation centre in Darlington, and six international health technology assessment bodies have formed a partnership to improve access to healthcare.

Popular documents

What is the difference between an appeal and a review?

What is the difference between an appeal and a review?What is an appeal?An appeal in insolvency proceedings is no different to an appeal in normal litigation. An appeal will be allowed only if the appeal court is satisfied that the decision of the lower court was 'wrong' or 'unjust because of a

Contributory negligence in personal injury claims

Contributory negligence in personal injury claimsContributory negligence is a partial defence which can lead to a discount in damages.Other defences may also be relevant. See Practice Notes: Did the claimant consent to the risk of injury? and Was the claimant involved in an illegal activity?If a

Can shares in a limited company that have not been paid-up at all be cancelled?

Can shares in a limited company that have not been paid-up at all be cancelled?A limited company having a share capital may not alter that share capital, except in the ways listed in section 617 of the Companies Act 2006 (CA 2006). Shares in a company cannot simply be cancelled without following an

Template for regulatory references given by SMCR firms and disclosure requirements

Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of